RecruitingPhase 2NCT07044635

Shortened Course of Radiation Therapy After Trans-oral Robotic Surgery in Patients With HPV-Mediated Oropharyngeal Squamous Cell Carcinoma.

Radiation Therapy in Reduced Dose and Hypofractionated Schedule After Trans-Oral Robotic Surgery in Intermediate Risk HPV-Mediated Oropharyngeal Squamous Cell Carcinoma


Sponsor

University of Utah

Enrollment

42 participants

Start Date

Jul 23, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this study is to evaluate if a shorter course of therapy can improve the quality of life in patients receiving radiation therapy after trans-oral robotic surgery.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a shorter course of radiation therapy (fewer sessions) works just as well as the standard longer course for people with HPV-related throat cancer (oropharyngeal cancer) who had robotic surgery to remove the tumor. Shorter radiation means fewer trips to the clinic and potentially fewer side effects. **You may be eligible if...** - You are 18 or older - You have been diagnosed with throat cancer (specifically oropharyngeal squamous cell carcinoma) linked to HPV - You had or are having robotic surgery through the mouth to remove the tumor - Your cancer is at an early to intermediate stage - You are a non-smoker or have not smoked in at least 1 month **You may NOT be eligible if...** - You have had previous head and neck radiation therapy - Your cancer has spread to distant parts of the body - You have had prior chemotherapy or cancer treatment recently - You have certain other active cancers Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONRadiation Therapy

Reduced dose and Hypofractionated radiation therapy


Locations(1)

Huntsman Cancer Institute/University of Utah

Salt Lake City, Utah, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07044635


Related Trials